Markets
November 2025
110 minutes

The Biotech Rebuild: Finding Alpha After the Drawdown with Chris Clark | #606

The Meb Faber Show

Chris Clark explains biotech’s post-drawdown landscape, differences between venture and public investing, and how regulation and AI shape drug development.

Read more
Portfolio Management
December 2023
65 minutes

Financing Biotech: Portfolio Theory and Netflix-Inspired Models

The Bioverge Podcast

MIT Professor of Finance Andrew Lo discusses his application of portfolio theory to address the challenges of funding drug development. […]

Read more
Markets
December 2023
91 minutes

For Blood and Money

The Compound and Friends

Nathan Vardi joins the show to discuss his book, For Blood and Money, the biotech investment landscape today, and stories of top […]

Read more
Markets
August 2023
55 minutes

Here’s How the New Weight Loss Drugs Could Change Everything

Odd Lots

James van Geelen of Citrinitas Capital’s James van Geelen shares how he’s evaluating the potential of new weight loss medications, how […]

Read more
Global Macroeconomics
March 2023
39 minutes

American Optimism with Joe Lonsdale

Raising Health

Serial entrepreneur & investor Joe Lonsdale shares what led him to become a co-founder of Palantir & Addepar, what factors […]

Read more
Markets
December 2022
21 minutes

A Prescription For Healthcare Investing

MIT economist & professor Andrew Lo shares what led him to want to help the biotech field better finance breakthrough […]

Read more
Markets
August 2022
41 minutes

Solving prescription drug pricing in the US with Cost Plus Drugs & Capital RX CEOs

This Week in Startups

For the first 41 minutes, Alex Oshmyansky, CEO of The Mark Cuban Cost Plus Drug Company, shares the purpose of Cost Plus, […]

Read more
Markets
February 2022
31 minutes

20VC: Mark Cuban on Reshaping the Pharmaceuticals Industry, How To Hire and Build Truly Great Teams and What Brand Really Means Today and How To Build One Successfully

Mark Cuban discusses disrupting the pharmaceutical supply chain, fixing structural inefficiencies in healthcare, and how mission driven businesses can reshape […]

Read more
Markets
July 2021
32 minutes

Dr. Rick Klausner on the Biotech Revolution | Season 1 Ep 1

Dr. Rick Klausner discusses the biotech revolution, how COVID and gene editing are accelerating innovation, and why aging and cancer […]

Read more
Markets
December 2020
39 minutes

The Machine That Made the Vaccine

Moderna CEO Stephane Bancel discusses mRNA vaccine development, the platform behind rapid design, and implications for the future of drug […]

Read more

Join our newsletter to have all of this content
+ Exclusive Newsletter Bonus Content
delivered to your inbox every week

Scroll to Top